Literature DB >> 9614313

Appropriate nutritional support in acute and complicated Crohn's disease.

D R Duerksen1, V Nehra, B R Bistrian, G L Blackburn.   

Abstract

Crohn's disease is frequently complicated by protein-calorie malnutrition. Four common clinical presentations of Crohn's disease include acute exacerbations or flares of disease, intestinal obstruction, fistulizing disease, and perianal disease. In this review, we examine the role of nutritional support in these clinical scenarios. Nutritional support is important for maintaining functional status and preventing loss of lean tissue. Determinants of lean-tissue loss include severity of underlying injury, baseline nutritional status, and duration of inadequate nutrition. One of the clinically useful measures of nutritional status is the nutritional risk index (NRI) defined on the basis of the serum albumin and weight loss. Nutritional support is important in severely malnourished patients (NRI < 83). Enteral nutrition is the route of choice, provided there are no contraindications to using the gastrointestinal tract. In acute exacerbations of Crohn's disease, enteral nutrition also has a role in the primary management of disease although it is not as effective as corticosteroids in inducing remission. The mechanisms are poorly understood and the most effective enteral formulation needs to be determined. Total parenteral nutrition is justified in severely malnourished Crohn's disease patients who are unable to tolerate enteral feeding or in whom enteral feeding is contraindicated. More clinical studies are needed on the assessment of malnutrition in Crohn's disease, the effects of nutritional management on functional status, and the timing of nutritional intervention.

Entities:  

Mesh:

Year:  1998        PMID: 9614313     DOI: 10.1016/s0899-9007(98)00019-7

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  6 in total

1.  Role of perioperative parenteral nutrition in severely malnourished patients with Crohn's disease.

Authors:  Guo-Xiang Yao; Xiu-Rong Wang; Zhu-Ming Jiang; Si-Yuang Zhang; An-Ping Ni
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

2.  Chios mastic treatment of patients with active Crohn's disease.

Authors:  Andriana C Kaliora; Maria G Stathopoulou; John K Triantafillidis; George V Z Dedoussis; Nikolaos K Andrikopoulos
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

Review 3.  Diet therapy for inflammatory bowel diseases: The established and the new.

Authors:  Franziska Durchschein; Wolfgang Petritsch; Heinz F Hammer
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

4.  Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial.

Authors:  M A Gassull; F Fernández-Bañares; E Cabré; M Papo; M H Giaffer; J L Sánchez-Lombraña; C Richart; H Malchow; F González-Huix; M Esteve
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

Review 5.  Importance of nutrition in inflammatory bowel disease.

Authors:  Alfredo José Lucendo; Livia Cristina De Rezende
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

6.  Evaluation of nutritional adequacy in adult patients with Crohn's disease: a cross-sectional study.

Authors:  Iolanda Cioffi; Nicola Imperatore; Olivia Di Vincenzo; Maria Carmen Pagano; Lidia Santarpia; Lucienne Pellegrini; Anna Testa; Maurizio Marra; Franco Contaldo; Fabiana Castiglione; Fabrizio Pasanisi
Journal:  Eur J Nutr       Date:  2020-02-18       Impact factor: 5.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.